Rotateq 2 ml Solution
PDF Leaflet Revision Date: 26 November 2015
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of rotavirus gastroenteritis in infants and children.
Dosage (summary)
Administer 3 doses orally starting at 6-12 weeks of age, with a minimum interval of 4 weeks.
Special Populations
- Pre-term infants
- Immunocompromised patients
Pregnancy & Breastfeeding
Not indicated for adults; safety in lactation not established.
Key Drug Interactions
- Oral poliovirus vaccine may reduce immune response
Contraindications
- Hypersensitivity to vaccine components
- Severe Combined Immunodeficiency Disease (SCID)
Common side effects
- Diarrhoea
- Vomiting
- Fever
Counselling Points
- Complete the vaccination series
- Report any adverse reactions
Serious warnings
- Risk of anaphylaxis
- Caution in immunocompromised individuals
Important Disclaimer
The Rotateq 2 ml Solution professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
